Contents
Download PDF
pdf Download XML
430 Views
140 Downloads
Share this article
Research Article | Volume 13 Issue:1 (, 2023) | Pages 144 - 152
Study to Compare Intravitreal Bevacizumab, Panretinal Photocoagulation or A Combination of Both in Proliferative Diabetic Retinopathy
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
Jan. 22, 2023
Abstract

Introduction: Diabetic retinopathy is a vascular condition of the retina that develops as a result of diabetes mellitus (DM). This study aimed to compare intravitreal bevacizumab, pan-retinal photocoagulation or a combination of both in proliferative diabetic retinopathy. Method: In this prospective, randomized interventional study, 180 patients with PDR were enrolled and divided into three equal groups, i.e., Group A-patients treated with laser alone and Group B- patients treated with Anti-VEGF alone and Group C- patients treated with Anti-VEGF and laser. A detailed history, clinical and demographical data of all the patients were recorded and compared.The examination was done, including visual acuity assessment with Snellen’s chart, Slit-lamp biomicroscopic examination, intraocular pressure and pupillary assessment for optic nerve dysfunction.

Keywords
Recommended Articles
Research Article
Assessing the Relationship Between Thiazide Use and Syncope Or Fall in Hypertensive Indian Subjects Admitted to the Tertiary Care Hospital
...
Published: 24/05/2025
Download PDF
Research Article
Evaluation of Matrix Metalloproteinases-3 As A Possible Biomarker For Oral Sub Mucous Fibrosis
Published: 24/11/2025
Download PDF
Research Article
Correlation Between Electrographic Changes and Troponin I Levels in Patients Presenting with Chest Pain in Emergency Medicine Department of Tertiary Care Centre
...
Published: 16/11/2025
Download PDF
Short Commentary Article
Commentary: Crystalline Precision: The Clinical Impact of Co-Crystal Formulation Differences in Sacubitril/Valsartan for HFrEF
Published: 22/11/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.